The global cardiac monitoring and cardiac rhythm management market was
worth $18.4 billion in the year 2012. Increasing incidence of
cardiovascular diseases, technological advancement, rising cost of
cardiac disease treatment, and government regulations in favor of
cardiac monitoringare is accelerating the growth of conventional
monitors as well as CRM devices. However, the economic slowdown and
unstable reimbursement policies will hamper the growth of this market,
to a certain exten.

The CRM devices market faced certain challenges in the recent past,
owing to research studies published in the Journal of the American
Medical Association (JAMA) and hospital investigations conducted by the
Department of Justice (DOJ), which reported the inappropriate use of
these devices. This affected the sales of CRM devices. The
defibrillators and pacemakers markets showed flat growth rates in the
U.S. from 2009 to 2011. However, with the technological advancements
such as introduction of MRI pacemakers, subcutaneous ICDs, and home
automated external defibrillators(AEDs), this market is expected to
bounce back.

The geographies covered in this study are North America, Europe, Asia
and Rest of the world (RoW). These four regions are further segmented by
major countries and geographic split for all the sub-segments is
presented at the regional level. North America is the largest market for
cardiac monitoring and cardiac rhythm management, followed by Europe and
Asia. North America and Europe is expected to grow at a slower pace
primarily due to the economic slowdown and market maturity. The Asian
market, especially India and China, is expected to witness a boost in
demand for cardiac monitoring and CRM products and is poised to register
maximum growth over the next five years, owing to the rising incidence
of cardiovascular diseases and increased purchasing power of patients.